Perspective Therapeutics (CATX) Other Operating Expenses (2010 - 2024)
Perspective Therapeutics (CATX) posted Other Operating Expenses of -$27000.0 for Q4 2024, up 55.74% sequentially from -$61000.0 in Q2 2024, and down 222.73% YoY from $22000.0 in Q1 2024.
Perspective Therapeutics (CATX) Other Operating Expenses (2010 - 2024) Analysis & Trends
Perspective Therapeutics has reported Other Operating Expenses for 15 years, with the latest figure at -$27000.0 in Q4 2024.
- Quarterly Other Operating Expenses fell 222.73% year-over-year to -$27000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$27000.0 (up 30.77% YoY) and the FY2024 annual result came in at -$27000.0, changed N/A from the prior year.
- Other Operating Expenses grew to -$27000.0 in Q4 2024 per CATX's latest filing, from -$61000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $805000.0 in Q1 2020 and troughed at -$1.2 million in Q2 2020.
- A 5-year average of $44583.3 and a median of -$4500.0 in 2020 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2020 and 2024: Other Operating Expenses surged 80400.0% in 2020, then plunged 222.73% in 2024.
- Over 5 years, Other Operating Expenses stood at -$7000.0 in 2020, then surged by 10128.57% to $702000.0 in 2021, then tumbled by 143.45% to -$305000.0 in 2022, then surged by 107.21% to $22000.0 in 2023, then slumped by 222.73% to -$27000.0 in 2024.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$27000.0, -$61000.0, and $22000.0 for Q4 2024, Q2 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 386.08 Mn | 386.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -27,000.00 |
| Jun 30, 2024 | -61,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Mar 31, 2023 | -22,000.00 |
| Dec 31, 2022 | -305,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Sep 30, 2021 | 702,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | -7,000.00 |
| Sep 30, 2020 | 581,000.00 |
| Jun 30, 2020 | -1.16 Mn |
| Mar 31, 2020 | 805,000.00 |
| Dec 31, 2019 | 277,000.00 |
| Sep 30, 2019 | 742,000.00 |
| Mar 31, 2019 | 1,000.00 |
| Dec 31, 2018 | 23,000.00 |
| Sep 30, 2018 | 649,000.00 |
| Jun 30, 2018 | 572,000.00 |
| Mar 31, 2018 | 692,000.00 |
| Dec 31, 2017 | 674,000.00 |